MedTrace Logo

Descriptive Analysis of Gut Microbiome Alterations in Hyperoxaluric Patients

NCT02794649 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2017-09-26

No results posted yet for this study

Summary

To characterize the microbiome in 4 groups of subjects (primary hyperoxaluria type I (PH1), idiopathic CaOx stone, enteric hyperoxaluria (EH) and healthy participants) by comparing the number of species and diversity of the microbial populations and pathway for oxalate metabolism by paralleling the gene expression of enzymes involved in oxalate degradation by gut bacteria.

Conditions

  • Oxalate, Primary Hyperoxaluria, Microbiome

Sponsors & Collaborators

  • Mayo Clinic

    collaborator OTHER

  • New York University

    collaborator OTHER

  • VA New York Harbor Healthcare System

    lead FED

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02794649 on ClinicalTrials.gov